Role of interleukin-18 and interleukin-10 in the formation of myocardial structural and functional changes in chronic obstructive pulmonary disease combined with hypertension
PDF (Українська)

Keywords

chronic obstructive pulmonary disease
hypertension
systemic inflammation
interleukin-18
interleukin-10
echocardiography

How to Cite

Kostyuk, I., & Melenevych, A. (2020). Role of interleukin-18 and interleukin-10 in the formation of myocardial structural and functional changes in chronic obstructive pulmonary disease combined with hypertension. Medicine Today and Tomorrow, 76(3–4), 48–54. Retrieved from https://msz.knmu.edu.ua/article/view/378

Abstract

Chronic obstructive pulmonary disease (COPD) is often combined with hypertension (HT) and contribute to maintaining persistent systemic inflammation. Levels of interleukin-18 (IL-18) and interleukin-10 (IL-10) in systemic blood flow were analyzed at patients with COPD in combination with HT, their significant increase compared to practically healthy and patients with isolated COPD was revealed. Reliable correlations between excessive content of the studied cytokines and hemodynamic parameters have been established, which may indicate the role of IL-18 and IL-10 in the genesis of structural and functional myocardial changes.

PDF (Українська)

References

Prevalence of comorbidities in chronic obstructive pulmonary disease patients / H. Yin, S. Yin, Q. Lin [et al.] // Medicine. – 2017. – Vol. 96, № 19. – e6836. – DOI: 10.1097/MD.0000000000006836.

Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease / M. Divo, C. Cote, J. P. de Torres [et al.] // Am. J. Respir. Crit. Care Med. – 2012. – Vol. 186, № 2. – P. 155–161. – DOI: 10.1164/rccm.201201-0034OC.

Martinon F. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β / F. Martinon, K. Burns, J. Tschopp // Mol. Cell. – 2002. – Vol. 10, № 2. – Р. 417–426. – DOI: 10.1016/S1097-2765(02)00599-3.

Guo H. Inflammasomes: mechanism of action, role in disease, and therapeutics / H. Guo, J. B. Callaway, J. P.-Y. Ting // Nat. Med. – 2015. – Vol. 21, № 7. – P. 677–687. – DOI: 10.1038/nm.3893.

Miao E. A. Caspase-1-induced pyroptotic cell death / E. A. Miao, J. V. Rajan, A. Aderem // Immunol. Rev. – 2011. – № 243. – Р. 206–214. – DOI: 10.1111/j.1600-065X.2011.01044.x.

De Nardo D. New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease / D. De Nardo, C. M. De Nardo, E. Latz // Am. J. Pathol. – 2014. – Vol. 184, № 1. – P. 42–54. – DOI: 10.1016/j.ajpath.2013.09.007.

IL-18 induces emphysema and airway and vascular remodeling via IFN-γ, IL-17A, and IL-13 / M. J. Kang, J. M. Choi, B. H. Kim [et al.] // Am. J. Respir. Crit. Care Med. – 2012. – V. 185, № 11. – P. 1205–1217. – DOI: 10.1164/rccm.201108-1545OC.

Role of IL-18 in second-hand smoke–induced emphysema / A. Kratzer, J. Salys, C. Nold-Petry [et al.] // Am. J. Respir. Cell Mol. Biol. – 2013. – Vol. 48, № 6. – P. 725–732. – DOI: 10.1165/rcmb.2012-0173OC.

2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) / G. Mancia, R. Fagard, K. Narkiewicz [et al.] // J. Hypertens. – 2013. – № 31 (7). – P. 1281–1357. – DOI: 10.1097/01.hjh.0000431740.32696.cc.